Vol 16, No 4 (2020)

Date published: 2020-08-17

Table of Contents

open access

GUIDELINES FOR DIAGNOSTIC AND THERAPEUTIC MANAGEMENT

Skin carcinomas

Piotr Rutkowski, Witold Owczarek, Dariusz Nejc, Arkadiusz Jeziorski, Wojciech M. Wysocki, Monika Słowińska, Monika Dudzisz-Śledź, Piotr Wiśniewski, Hanna Koseła-Paterczyk, Dorota Kiprian, Tomasz Świtaj, Marcin Zdzienicki, Adam Maciejczyk, Lidia Rudnicka

Guidelines / Expert consensus

DOI: 10.5603/OCP.2020.0018
Oncol Clin Pract 2020;16(4):143-162.

Cutaneous melanoma

Piotr Rutkowski, Piotr J. Wysocki, Anna Nasierowska-Guttmejer, Arkadiusz Jeziorski, Wojciech M. Wysocki, Ewa Kalinka, Tomasz Świtaj, Katarzyna Kozak, Grażyna Kamińska-Winciorek, Anna M. Czarnecka, Hanna Koseła-Paterczyk, Piotr Wiśniewski, Anna Szumera-Ciećkiewicz, Marcin Zdzienicki, Bożena Cybulska-Stopa, Marek Ziobro, Jacek Fijuth, Andrzej Kawecki, Lidia Rudnicka, Witold Owczarek, Maciej Krzakowski

Guidelines / Expert consensus

DOI: 10.5603/OCP.2020.0021
Oncol Clin Pract 2020;16(4):163-182.

Clinical practice guidelines for diagnosis and treatment of colon (C18) and rectosigmoid junction (C19) cancer

Piotr Potemski, Krzysztof Bujko, Andrzej Rutkowski, Maciej Krzakowski

Guidelines / Expert consensus

DOI: 10.5603/OCP.2020.0030
Oncol Clin Pract 2020;16(4):183-193.
ORIGINAL ARTICLE

Immunotherapy or targeted therapy as first-line treatment of patients with advanced/metastatic melanoma with the BRAF mutation — a single-center analysis

Bożena Cybulska-Stopa, Karolina Piejko, Renata Pacholczak, Małgorzata Domagała-Haduch, Anna Drosik-Kwaśniewska, Agata Sałek-Zań, Patrycja Wiktor-Mucha, Janusz Rolski, Tomasz Zemełka

Research paper

DOI: 10.5603/OCP.2020.0023
Oncol Clin Pract 2020;16(4):194-200.
REVIEW ARTICLES

Neratinib in extended adjuvant therapy for HER2-positive early breast cancer

Tomasz Kubiatowski

Review paper

DOI: 10.5603/OCP.2020.0013
Oncol Clin Pract 2020;16(4):201-205.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl